EUVIMEDEUVIMED entdecken
Open Access

Estimated Cancer Risk in Females Who Meet the Criteria to Exit Cervical Cancer Screening

Shalini L Kulasingam, Inge M C M de Kok, Abhinav Mehta, Erik E L Jansen, Mary Caroline Regan, James W Killen, Stephen Sy, Ran Zhao, Karen Canfell, Jane J Kim, Megan A Smith, Nicole G Campos

JAMA Network Open · 12.03.2025 · 8 (3) · e250479

DOI: 10.1001/jamanetworkopen.2025.0479 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 12.03.2025. Verfasst von Shalini L Kulasingam und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Early Detection of Cancer, Uterine Cervical Dysplasia, Mass Screening. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Cervical screening guidelines in the US recommend that most females can exit routine screening at age 65 years following 2 recent consecutive negative cotest results (concurrent human papillomavirus and cytology tests). However, empirical data on the subsequent risks of cancer and cancer death in this subgroup of females are limited.

Objective

To estimate the risks of cervical cancer and cervical cancer death among females who meet the cotesting criteria to exit screening. Design, Setting, and Participants In this decision analytical comparative modeling study, 4 decision analytical models from the Cancer Intervention and Surveillance Modeling Network–Cervical modeling consortium that fit common US epidemiological data targets were validated against published estimates of 3- and 5-year risks of cervical intraepithelial neoplasia grade 3 (CIN3) among females meeting exit criteria at Kaiser Permanente Northern California (KPNC). Main Outcomes and Measures Age-conditional and cumulative risks of cervical cancer and cervical cancer death at ages 65, 70, 75, 80, and 85 years were estimated by performing a comparative modeling analysis of the 4 models to estimate the risks of cervical cancer and cervical cancer death after exiting screening.

Results

All models estimated a 5-year risk of CIN3 that was within the range of empirical data from KPNC. Projections of the cumulative and age-conditional risks of cervical cancer and cervical cancer death increased with time since exiting screening. The cumulative risks of cervical cancer and cervical cancer death by age 70 years were estimated to range from 0.001% to 0.003% and from 0% to 0.001%, respectively. The cumulative risks of cervical cancer and cervical cancer death by age 85 years ranged from 0.026% to 0.081% and from 0.005% to 0.038%, respectively, across models. Results were sensitive to assumptions about screening test sensitivity and incidence of high-risk human papillomavirus. Conclusions and Relevance In this decision analytical comparative modeling study, a low risk of cervical cancer and cervical cancer death was estimated among females who fulfilled the US criteria to exit screening with cotesting; however, the risks increased with age and/or time since screening exit. The findings suggest that future guidelines should consider acceptable risk levels when defining screening modality and exit age requirements.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsEarly Detection of CancerUterine Cervical DysplasiaMass ScreeningHumansFemaleAgedAged, 80 and overRisk AssessmentCaliforniaPapillomavirus Infections

Autor:innen und Institutionen

  • Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis.
  • Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • The Daffodil Centre, University of Sydney, a joint venture with Cancer Council New South Wales, Sydney, Australia.

Förderung

  • NCI NIH HHS

Zitieren

APA

Kulasingam, S. L., de Kok, I. M. C. M., Mehta, A., Jansen, E. E. L., Regan, M. C., Killen, J. W., Sy, S., Zhao, R., Canfell, K., Kim, J. J., Smith, M. A., & Campos, N. G. (2025). Estimated Cancer Risk in Females Who Meet the Criteria to Exit Cervical Cancer Screening. JAMA Network Open, 8(3), e250479. https://doi.org/10.1001/jamanetworkopen.2025.0479

Vancouver

Kulasingam SL, de Kok IMCM, Mehta A, Jansen EEL, Regan MC, Killen JW, et al. Estimated Cancer Risk in Females Who Meet the Criteria to Exit Cervical Cancer Screening. JAMA Network Open. 2025;8(3):e250479. doi:10.1001/jamanetworkopen.2025.0479

BibTeX
@article{Kulasingam2025,
  author = {Kulasingam, Shalini L and de Kok, Inge M C M and Mehta, Abhinav and Jansen, Erik E L and Regan, Mary Caroline and Killen, James W and Sy, Stephen and Zhao, Ran and Canfell, Karen and Kim, Jane J and Smith, Megan A and Campos, Nicole G},
  title = {Estimated Cancer Risk in Females Who Meet the Criteria to Exit Cervical Cancer Screening},
  journal = {JAMA Network Open},
  year = {2025},
  volume = {8},
  number = {3},
  pages = {e250479},
  doi = {10.1001/jamanetworkopen.2025.0479}
}
Kostenlos starten →